Chen Lingli, Zhang Yan, Li Yi, Song Chao, Lin Fengyu, Pan Pinhua
Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China.
Front Med (Lausanne). 2022 Feb 7;9:817689. doi: 10.3389/fmed.2022.817689. eCollection 2022.
The coronavirus disease (COVID-19) pandemic has significantly increased the number of patients with acute respiratory distress syndrome (ARDS), necessitating respiratory support. This strain on intensive care unit (ICU) resources forces clinicians to limit the use of mechanical ventilation by seeking novel therapeutic strategies. Awake-prone positioning appears to be a safe and tolerable intervention for non-intubated patients with hypoxemic respiratory failure. Meanwhile, several observational studies and meta-analyses have reported the early use of prone positioning in awake patients with COVID-19-related ARDS (C-ARDS) for improving oxygenation levels and preventing ICU transfers. Indeed, some international guidelines have recommended the early application of awake-prone positioning in patients with hypoxemic respiratory failure attributable to C-ARDS. However, its effectiveness in reducing intubation rate, mortality, applied timing, and optimal duration is unclear. High-quality evidence of awake-prone positioning for hypoxemic patients with COVID-19 is still lacking. Therefore, this article provides an update on the current state of published literature about the physiological rationale, effect, timing, duration, and populations that might benefit from awake proning. Moreover, the risks and adverse effects of awake-prone positioning were also investigated. This work will guide future studies and aid clinicians in deciding on better treatment plans.
冠状病毒病(COVID-19)大流行显著增加了急性呼吸窘迫综合征(ARDS)患者的数量,这使得呼吸支持成为必要。重症监护病房(ICU)资源的这种紧张状况迫使临床医生通过寻求新的治疗策略来限制机械通气的使用。对于低氧性呼吸衰竭的非插管患者,清醒俯卧位似乎是一种安全且可耐受的干预措施。同时,多项观察性研究和荟萃分析报告了在清醒的COVID-19相关ARDS(C-ARDS)患者中早期使用俯卧位可改善氧合水平并防止转入ICU。事实上,一些国际指南已建议在因C-ARDS导致低氧性呼吸衰竭的患者中早期应用清醒俯卧位。然而,其在降低插管率、死亡率、应用时机和最佳持续时间方面的有效性尚不清楚。关于COVID-19低氧患者清醒俯卧位的高质量证据仍然缺乏。因此,本文提供了关于已发表文献的最新情况,内容涉及清醒俯卧位的生理原理、效果、时机、持续时间以及可能受益的人群。此外,还调查了清醒俯卧位的风险和不良反应。这项工作将指导未来的研究,并帮助临床医生制定更好的治疗方案。